Health Prevention and Protection Service, General Directorate of Public Health and Addictions, Health Council, Region de Murcia, Spain.
Immunotherapy and Vaccines Unit, AstraZeneca Farmacéutica Spain SA, Medical Department, Madrid, Spain.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2328406. doi: 10.1080/21645515.2024.2328406. Epub 2024 Apr 4.
During the 2022-2023 season, the Region of Murcia (an autonomous community of Spain) introduced the influenza vaccination campaign in children aged 24-59 months with the live-attenuated influenza nasal spray vaccine. To expand coverage, a pilot study was conducted to include the 3- to 4-year population in 24 public schools. The aim of the study was to assess the experiences of parents and teachers involved in the project. This was a psychosocial qualitative study in which information was collected from a cohort of 23 parents and 17 teachers who attended three and two focus group sessions, respectively. A high degree of satisfaction with the school-located influenza vaccination program was consistently reported. The teachers reported creating a friendly environment and acting as companions to support children in the absence of their parents. They also considered the intranasal route, which avoids intramuscular puncture, as a facilitating element that turned the vaccination process into a kind of game. Parents emphasized the importance of vaccination to protect their children, and secondarily, to ensure protection of the family nucleus. Some parents who had their children already vaccinated in the health care center reported preference for the school setting, probably selecting this option in the future. The availability of school-based influenza vaccination promoted greater equity in accessing the vaccine and facilitated family reconciliation. To optimize coverage and minimize potential reluctance, providing the necessary information to parents both before and after vaccination was considered. School-located influenza vaccination was feasible and is a valuable strategy to be implemented in future campaigns.
在 2022-2023 赛季,西班牙穆尔西亚自治区(一个自治区)向 24-59 月龄的儿童推出了流感疫苗接种活动,使用的是减毒活流感鼻喷疫苗。为了扩大接种范围,开展了一项试点研究,将 24 所公立学校的 3-4 岁儿童纳入其中。本研究旨在评估参与项目的家长和教师的经验。这是一项社会心理学定性研究,分别从 23 名家长和 17 名教师组成的队列中收集信息,他们参加了三次和两次焦点小组会议。研究结果显示,家长和教师对学校接种流感疫苗计划的满意度很高。教师们报告称,他们营造了一个友好的环境,并在没有家长陪伴的情况下充当孩子们的同伴,支持他们接种疫苗。他们还认为,这种鼻腔接种途径避免了肌肉注射,是一种使接种过程变得像游戏一样的便利元素。家长们强调了接种疫苗的重要性,以保护他们的孩子,其次是保护家庭核心成员。一些已经在保健中心为孩子接种过疫苗的家长表示更喜欢在学校接种,可能会在未来选择这种方式。学校接种流感疫苗促进了更大的公平性,方便了家庭的协调。为了优化覆盖率并尽量减少潜在的抵触情绪,认为有必要在接种前后向家长提供必要的信息。学校接种流感疫苗是可行的,是未来推广疫苗接种的一项有价值的策略。